These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis. Pleskow W, Grubbe R, Weiss S, Lutsky B. Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245 [Abstract] [Full Text] [Related]
24. Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU). Day JH, Briscoe MP, Rafeiro E, Ratz JD. Int J Clin Pract; 2004 Feb; 58(2):109-18. PubMed ID: 15055856 [Abstract] [Full Text] [Related]
25. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. Ciebiada M, Ciebiada MG, Kmiecik T, DuBuske LM, Gorski P. J Investig Allergol Clin Immunol; 2008 Feb; 18(5):343-9. PubMed ID: 18973097 [Abstract] [Full Text] [Related]
26. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis. Greiff L, Persson CG, Andersson M. Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387 [Abstract] [Full Text] [Related]
28. Levocetirizine better protects than desloratadine in a nasal provocation with allergen. Deruaz C, Leimgruber A, Berney M, Pradervand E, Spertini F. J Allergy Clin Immunol; 2004 Apr; 113(4):669-76. PubMed ID: 15100671 [Abstract] [Full Text] [Related]
36. Impact and modulation of nasal obstruction. Horak F. Allergy; 2002 Apr; 57 Suppl 75():25-8. PubMed ID: 12492726 [Abstract] [Full Text] [Related]
37. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH, Briscoe M, Widlitz MD. J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501 [Abstract] [Full Text] [Related]
40. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. Berger WE, White MV, Rhinitis Study Group. Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]